FDA Advisory Committees Meet on Avandia Safety
Rate:
39,772 ratings
Views: 720
From: MDedge: news and insights for busy physicians
Added: 16 years ago · 1:55 · 480p
Two Food and Drug Administration advisory panels discussed the future of the diabetes drug Avandia (rosiglitazone).
Comments
No comments yet.